Hercules Capital, Inc. filings document the regulatory reporting of a specialty finance company that provides senior secured venture growth loans to technology and life sciences businesses. Its Form 8-K filings cover earnings releases, operating and financial condition updates, cash distribution declarations, executive leadership changes and related exhibits.
Proxy materials describe annual meeting matters, board governance, executive compensation and equity-award disclosures. The company’s filings also identify its NYSE-listed common stock under HTGC and its 6.25% Notes due 2033 under HCXY, tying capital-structure disclosures to both equity and debt securities.
Hercules Capital, Inc. reported an insider transaction by its Chief Executive Officer, Scott Bluestein. On October 11, 2025, 13,431 shares of common stock were withheld to cover taxes upon the vesting of restricted stock (Transaction Code F) at a price of $16.7 per share. Following this tax-withholding event, Bluestein beneficially owns 2,244,097 shares, held directly.
Hercules Capital, Inc. (HTGC) – Form 4 filing: Chief Legal Officer & Chief Compliance Officer Kiersten Zaza Botelho reported an automatic share withholding on 9 July 2025 related to the vesting of restricted stock. The company withheld 912 common shares at a price of $18.56 per share to cover applicable taxes (Transaction Code F). Following the transaction, the executive retains 66,651 directly held shares. Because the shares were not sold on the open market and merely satisfied tax obligations, the event neither increases nor decreases the executive’s economic exposure to HTGC and is typically viewed as administrative rather than directional trading activity.